Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Rhatany root (Krameria triandra and related Krameria species) is a tannin-rich medicinal root containing oligomeric proanthocyanidins that form astringent mucosal-protective barriers (PMID 2813572), lipophilic neolignans with demonstrated antioxidant and photoprotective activity that reduce UV-induced lipid peroxidation (PMID 11914952), and bioactive benzofurans such as ratanhiaphenol III that inhibit protein tyrosine phosphatase 1B (PTP1B), a key metabolic target (PMID 22307937). Recent research has further revealed anti-inflammatory cycloartanes that inhibit COX-1 and COX-2 enzymes (PMID 23161426), endothelial nitric oxide synthase (eNOS)-activating neolignans that promote vascular health (PMID 22771373), and potent anti-eimerial and anti-apoptotic properties relevant to immune defense (PMID 39055709).
Reported Benefits (Provisional)
Origin & History
Rhatany root (Krameria lappacea) is derived from a shrub native to the high-altitude regions of the Andes Mountains in Peru and Bolivia. Traditionally valued for its astringent and anti-inflammatory properties, it is recognized in functional nutrition for its potential to support oral, digestive, and skin health.
Research Narrative (Provisional)
Scholz et al. (1989) characterized oligomeric proanthocyanidins from Krameria triandra root as the principal astringent tannins conferring mucosal-protective and hemostatic activity (Planta Medica, PMID 2813572). Carini et al. (2002) demonstrated that a lipophilic neolignan extract from K. triandra roots significantly reduced UV-induced lipid peroxidation in vitro, establishing antioxidant and photoprotective efficacy (Planta Medica, PMID 11914952). Heiss et al. (2012) identified ratanhiaphenol III from Ratanhiae radix as a selective inhibitor of protein tyrosine phosphatase 1B (PTP1B), a validated target in type 2 diabetes and obesity research (Planta Medica, PMID 22307937). Ramírez-Cisneros et al. (2012) isolated cycloartane triterpenoids from Krameria pauciflora that inhibited phospholipase A₂ (PLA₂), COX-1, and COX-2 enzymes in vitro, confirming multi-target anti-inflammatory activity (Planta Medica, PMID 23161426), while a parallel study from the same group demonstrated antidiabetic and free radical scavenging properties of K. pauciflora methanol extract (Molecules, PMID 22252502).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Tannins: Potent astringents and antioxidants, responsible for anti-inflammatory and antimicrobial effects. - Flavonoids and Proanthocyanidins: Provide additional antioxidant protection. - Phenolic Compounds: Contribute to its bioactive profile. - Minerals: Calcium, magnesium, and potassium for various physiological functions. - Saponins and Alkaloids: Contribute to traditional medicinal uses.
Reported Mechanism (Provisional)
The oligomeric proanthocyanidins (historically termed rhataniatannic acid) identified by Scholz et al. (PMID 2813572) precipitate salivary and mucosal glycoproteins on tissue surfaces, forming a protective astringent barrier that reduces epithelial permeability, inhibits bacterial adhesion, and provides hemostatic and anti-inflammatory effects. Ratanhiaphenol III, a neolignan benzofuran, selectively inhibits PTP1B (PMID 22307937), a negative regulator of insulin and leptin signaling, thereby enhancing insulin receptor phosphorylation and downstream PI3K/Akt pathway activation relevant to glucose homeostasis. The related benzofuran neolignan 2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran promotes endothelial nitric oxide synthase (eNOS) activity in human endothelial cells (PMID 22771373), increasing nitric oxide bioavailability and supporting vasodilation and vascular protection. Cycloartane triterpenoids from K. pauciflora inhibit PLA₂, COX-1, and COX-2 enzymes (PMID 23161426), blocking arachidonic acid release and prostaglandin biosynthesis to exert multi-level anti-inflammatory effects.
Clinical Narrative (Provisional)
A 30-day clinical trial demonstrated topical Krameria triandra extract reduced gum bleeding by 40% in human participants. In murine studies, rhatany root extract reduced caspase-3 immunoreactivity to 4.66 ± 0.57 compared to infected controls and upregulated protective MUC2 goblet cell expression. In vitro anticancer studies showed 2.2-fold ROS increase, 59% GSH depletion, and 68% mitochondrial membrane potential loss at 1000 μg/mL. Evidence remains preliminary with limited large-scale human trials for internal therapeutic applications.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.